Moreover, GP73 tends to be used as a useful biomarker to monitor HCC prognosis after primary tumour surgery and therapy in advanced HCC.132, 133 In terms of clinical application, it is still a new biomarker, and large‐scale and multi‐centred investigations are still needed. The gene discussed is GOLM1; the disease is neoplasm.